Based on the key indicators related to Sensei Biotherapeutics' liquidity, profitability, solvency, and operating efficiency, Sensei Biotherapeutics is not in a good financial situation at this time. It has a very high odds of going through financial crisis in April. At present, Sensei Biotherapeutics' Total Current Liabilities is projected to increase significantly based on the last few years of reporting. The current year's Total Stockholder Equity is expected to grow to about 78.4 M, whereas Short and Long Term Debt Total is forecasted to decline to about 5.1 M. Key indicators impacting Sensei Biotherapeutics' financial strength include:
The essential information of the day-to-day investment outlook for Sensei Biotherapeutics includes many different criteria found on its balance sheet. An individual investor should monitor Sensei Biotherapeutics' cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Sensei Biotherapeutics.
Please note, the presentation of Sensei Biotherapeutics' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Sensei Biotherapeutics' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Sensei Biotherapeutics' management manipulating its earnings.
Sensei Biotherapeutics Stock Summary
Sensei Biotherapeutics competes with Vor Biopharma, and Evaxion Biotech. Sensei Biotherapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of immunotherapies with an initial focus on treatments for cancer. Sensei Biotherapeutics, Inc. was incorporated in 1999 and is headquartered in Rockville, Maryland. Sensei Biotherapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 56 people.
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
Comparative valuation techniques use various fundamental indicators to help in determining Sensei Biotherapeutics's current stock value. Our valuation model uses many indicators to compare Sensei Biotherapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Sensei Biotherapeutics competition to find correlations between indicators driving Sensei Biotherapeutics's intrinsic value. More Info.
Sensei Biotherapeutics is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers . At present, Sensei Biotherapeutics' Return On Equity is projected to slightly decrease based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Sensei Biotherapeutics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
Sensei Biotherapeutics Systematic Risk
Sensei Biotherapeutics' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Sensei Biotherapeutics volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Sensei Biotherapeutics correlated with the market. If Beta is less than 0 Sensei Biotherapeutics generally moves in the opposite direction as compared to the market. If Sensei Biotherapeutics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Sensei Biotherapeutics is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Sensei Biotherapeutics is generally in the same direction as the market. If Beta > 1 Sensei Biotherapeutics moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Sensei Biotherapeutics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Sensei Biotherapeutics' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Sensei Biotherapeutics growth as a starting point in their analysis.
Price Earnings To Growth Ratio
0.023
At present, Sensei Biotherapeutics' Price Earnings To Growth Ratio is projected to slightly decrease based on the last few years of reporting.
Sensei Biotherapeutics March 24, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Sensei Biotherapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Sensei Biotherapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Sensei Biotherapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Sensei Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Sensei Biotherapeutics's daily price indicators and compare them against related drivers.
When running Sensei Biotherapeutics' price analysis, check to measure Sensei Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sensei Biotherapeutics is operating at the current time. Most of Sensei Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Sensei Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sensei Biotherapeutics' price. Additionally, you may evaluate how the addition of Sensei Biotherapeutics to your portfolios can decrease your overall portfolio volatility.